Vor Biopharma Q1 2026 Earnings Wide EPS Miss Sends Stock Down 47 Amid Ongoing Clinical Development PANW Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction HBANL Q1 2026 Earnings Preferred Shares Edge Up Despite Significant EPS Miss RBKB Q1 2026 Earnings EPS of 020 Reported Amid Stock Decline RCEL Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress PAA Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Resilience